NURS FPX 4900 Assessment 1 Assessing the Problem: Leadership Collaboration Communication Change Management and Policy Considerations Evidence-Based Approach 

The primary objective of HTN management is to attain and sustain a targeted level of BP and manage hypertensive adults over the age of 60). Lifestyle modifications, including nutritional therapies (reducing salt intake, increasing electrolytes, eliminating alcohol, and multifactorial dietary regulation), weight reduction, quitting smoking, regular exercise, and managing stress, should be the preliminary stage in HTN management. A comprehensive strategy to intervention may help lower blood pressure in senior patients with HTN. Multidisciplinary strategies to HTN management that use collaborative management amongst doctors, nursing staff, clinicians, nutritionists, and physical therapists have significant benefits over typical general practitioner therapy—broadening the reach of procedure for health healthcare staff, chemists, and allied health professionals’ evaluation, prescribing, and providing a systematic therapy as a component of coherent partnerships. It creates an opportunity to confront such shortfalls in achieving BP goals. Further study on intervention strategies that include numerous healthcare professionals as representatives of a treatment team, and also intervention strategies by nutrition experts as well as physical therapists are required to ascertain the highest quality approaches for collaborative efforts as well as the implementation of broadening clinical expertise, such as individualized prescribed medication by prescribers and nursing staff, where accessible. 

American Heart Association (AHA) hypertensive guidelines include almost every aspect of hypertensive assessment, examination, screening, related complications, medications, and quasi-treatment. In all situations where reliable blood pressure measurements are desired, considerable and suitable emphasis has been paid to the processes necessary for reliable BP measurement. Many “failures” in blood pressure monitoring raise concerns, resulting in over-diagnosis of HTN and, in patients already on pharmaceutical intervention, underestimating the extent of blood pressure decrease. The vast percentage of people with stage 1 HTN does not require immediate pharmacological therapy. A considerable amount of recommendations in the guidelines are innovative.

Whenever stage 1 HTN and high-risk patient characteristics such as age 65 years or above, metabolic syndrome, renal failure, and recognized heart disease are nonexistent, the ultimate cardiovascular hazard is being used to decide elevated condition; high-risk individuals start pharmacotherapy when BP is 135/90 mmHg. Recurrent stroke treatment in persons without knowledge has been an outlier among high-risk patients since pharmaceutical intervention has been introduced. People who are not at elevated danger will start taking prescription intervention when their BP is 135/100 mmHg. Irrespective of the BP threshold for initiating pharmaceutical administration, many individuals’ target BP is at a minimum of 120/80